Interleaved Chirp Spreading LoRa-Based Modulation With Continuous Phase
IEEE Communications Letters · 2025-05 · 29 (5) · 873-877
DOI: 10.1109/lcomm.2024.3482276 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Communications Letters, 2025-05. Verfasst von Lei Wang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Exploration for new dimensions to convey information is a non-trivial task for resource-limited communications. Interleaved Chirp Spreading LoRa (ICS-LoRa) constitutes a new multi-dimensional space from the interleaved versions of LoRa waveforms to convey extra bits. Nevertheless, it destroys the phase continuity of LoRa waveforms and degrades the spectral localization, offsetting the benefit from the increased symbol payload size. This letter fully elaborates the potential of the interleaving dimension and proposes a continuous phase ICS-LoRa scheme, which is proven to be more efficient in data rate improvement than ICS-LoRa. Furthermore, a low-complexity design from the proposed scheme is provided for implementation simplicity.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, L., & Wang, M. M. (2025). Interleaved Chirp Spreading LoRa-Based Modulation With Continuous Phase. IEEE Communications Letters, 29(5), 873-877. https://doi.org/10.1109/lcomm.2024.3482276
Vancouver
Wang L, Wang MM. Interleaved Chirp Spreading LoRa-Based Modulation With Continuous Phase. IEEE Communications Letters. 2025;29(5):873-877. doi:10.1109/lcomm.2024.3482276
BibTeX
@article{Wang2025,
author = {Wang, Lei and Wang, Michael M.},
title = {Interleaved Chirp Spreading LoRa-Based Modulation With Continuous Phase},
journal = {IEEE Communications Letters},
year = {2025},
volume = {29},
number = {5},
pages = {873--877},
doi = {10.1109/lcomm.2024.3482276}
}
EUVIMED